AR042595A1 - Composiciones de meningococos con adyuvante - Google Patents
Composiciones de meningococos con adyuvanteInfo
- Publication number
- AR042595A1 AR042595A1 ARP020103745A ARP020103745A AR042595A1 AR 042595 A1 AR042595 A1 AR 042595A1 AR P020103745 A ARP020103745 A AR P020103745A AR P020103745 A ARP020103745 A AR P020103745A AR 042595 A1 AR042595 A1 AR 042595A1
- Authority
- AR
- Argentina
- Prior art keywords
- meningococes
- assistant
- compositions
- combination
- neisserial
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 241001212279 Neisseriales Species 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000011859 microparticle Substances 0.000 abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
Landscapes
- Biological Depolymerization Polymers (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Combinación de oligonucleótidos CpG y micropartículas extremadamente eficaz como adyuvante para antígenos de Neisserial. Una combinación que comprende (a) un antígeno de Neisserial; (b) un oligonucleótido CpG; y (c) una micropartícula polimérica biodegradable.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32692901P | 2001-10-03 | 2001-10-03 | |
| PCT/US2002/010869 WO2002080648A2 (en) | 2001-04-05 | 2002-04-05 | Mucosal boosting following parenteral priming |
| US37354702P | 2002-04-17 | 2002-04-17 | |
| US38067702P | 2002-05-13 | 2002-05-13 | |
| US25443802A | 2002-09-24 | 2002-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR042595A1 true AR042595A1 (es) | 2005-06-29 |
Family
ID=42938593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103745A AR042595A1 (es) | 2001-10-03 | 2002-10-03 | Composiciones de meningococos con adyuvante |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR042595A1 (es) |
| MX (1) | MXPA04003186A (es) |
-
2002
- 2002-10-03 MX MXPA04003186A patent/MXPA04003186A/es active IP Right Grant
- 2002-10-03 AR ARP020103745A patent/AR042595A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04003186A (es) | 2004-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR026940A1 (es) | Composicion farmaceuticas para modulacion inmunologica y preparacion de vacunas | |
| CO5070674A1 (es) | Vacunas con un oligonucleotido cpg como adyuvante | |
| MXPA02008283A (es) | Sistema de manejo termico. | |
| BR0213119A (pt) | Composição imunogênica e uso da mesma | |
| DOP2006000050A (es) | Una formulación sólida de dosificación farmaceútica | |
| AR074501A1 (es) | Oligonucleotidos inmunoestimuladores | |
| CO5540349A2 (es) | Preparacion vacunal de virus de influenza inactivado | |
| WO2001078768A3 (en) | Targeted vaccine delivery systems | |
| EP1290928A4 (en) | Heatsink and heatsink device using the heatsink | |
| GT200500294A (es) | Oligonucleotidos inmunoestimuladores de clase c semiblandos | |
| BR0207279A (pt) | Dispositivo de injeção de vertebroplastia e cimento para osso para o mesmo | |
| ATE541587T1 (de) | Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen | |
| PT1187629E (pt) | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador | |
| EP1318798A4 (en) | PROPOFOL-BASED WATER-SOLUBLE DRUGS TO TREAT MIGRAINE | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| BRPI0510568A (pt) | copolìmero, processo para preparação do mesmo, partìcula biodegradável, uso da mesma, processo para preparação de um sistema de liberação, composição para perfumar, e, produto perfumado | |
| CY1108526T1 (el) | Εμβολια εναντι καρκινων | |
| BRPI0508064A (pt) | flavivìrus, composição de vacina e molécula de ácido nucléico | |
| ATE419008T1 (de) | Adjuvante zusammensetzung und anwendungsverfahren dafür | |
| ES2171737T3 (es) | Conjugados de metaloceno-fosforamidita, procedimiento para producirlos y utilizacion de los mismos. | |
| PA8571901A1 (es) | Nueva composicion farmaceutica | |
| DE60222868D1 (de) | Strahlungshärtbare Zusammensetzungen enthaltend hochverzweigte, Acrylat-Endgruppen aufweisende, Polyestere | |
| AR051385A1 (es) | Agentes de curtido a base de isocianato | |
| AR042595A1 (es) | Composiciones de meningococos con adyuvante | |
| EP1301208A4 (en) | Vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |